Helen Torley - Feb 10, 2024 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
PRESIDENT AND CEO, Director
Signature
/s/ James R. Oehler, Attorney-in-Fact
Stock symbol
HALO
Transactions as of
Feb 10, 2024
Transactions value $
-$601,307
Form type
4
Date filed
2/13/2024, 04:12 PM
Previous filing
Aug 31, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +31.3K +5.02% $0.00 655K Feb 10, 2024 Direct
transaction HALO Common Stock Tax liability -$601K -16.9K -2.59% $35.49 638K Feb 10, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -31.3K -100% $0.00* 0 Feb 10, 2024 Common Stock 31.3K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 16,943 shares represents the shares that were withheld by the issuer as payment for minimum statutory tax withholding obligations.
F2 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.